Although DePuy Orthopaedics recalled its ASR XL Acetabular System and ASR Hip Resurfacing System in 2010 after the devices failed at alarming rates, DePuy hip implant injuries remain a global concern. DePuy, and its parent corporation Johnson & Johnson, are now facing more than 150 hip implant lawsuits from South African patients. South African Woman’s Painful Journey According to a news report from Independent Online, 62-year-old Cape Town resident Martha Maria de Kock has undergone three hip implant replacements using… Read More
Category: <span>DePuy</span>
The first DePuy Orthopaedics hip implant injury trial representing a complaint consolidated in MDL (multi-district litigation) will begin in June 2013. The bellwether trial comes on the heels of the first non-MDL DePuy hip implant trial, in which a jury awarded the plaintiff $8.3 million in damages. What the Bellwether Trial Means to You DePuy Orthopaedics, a subsidiary of Johnson & Johnson, faces thousands of lawsuits over its metal-on-metal ASR XL Acetabular Hip Implant and ASR Hip Resurfacing System, which… Read More
Johnson & Johnson (J&J) has long referred to itself as a family of companies. However, some say that the way that the company currently handles lawsuits filed against it and its subsidiaries is very different – and less family friendly – than it was years ago. In fact, it may even violate its own policies. 30 Years Ago vs. Present Day Many Americans remember a time when large pharmaceutical companies, such as J&J, acted more responsibly and put customer safety… Read More
The president of DePuy Orthopaedics, Andrew Ekdahl, recently testified that the company’s recall of 93,000 ASR XL metal-on-metal hip implant devices was for clinical reasons – and not because the product was defective. Ekdahl’s recent testimony was presented at the second trial against the company in Illinois. The first trial resulted in a California jury’s award of $8.3 million to the plaintiff. Approximately 11,000 similar lawsuits are pending throughout the nation. DePuy Maintains Hip Implants Were Not Defective Ekdahl and… Read More
Just days after a California jury awarded a DePuy hip implant victim $8.3 million in damages, the second of nearly 11,000 lawsuits against medical device manufacturers DePuy Orthopaedics and parent company Johnson & Johnson is now underway. From California To Chicago The second DePuy hip injury lawsuit trial is now underway in Chicago. The plaintiff, Carol Strum, a 54-year-old Illinois nurse, sued the medical device giants, alleging not only that her implanted DePuy ASR was defective but also that the… Read More
The first of nearly 11,000 trials pending against DePuy’s recalled ASR XL hip implant has resulted in an $8.3 million verdict for the plaintiff, 65-year-old Loren Kransky of Montana. Was this verdict an anomaly? Or could it set the bar for other victims waiting their turn in court? Breakdown Of The $8.3M Verdict The first DePuy ASR XL hip implant trial resulted in an $8.3 million jury verdict against the manufacturer – $338,136 in compensatory damages and another $8 million… Read More
The U.S. Department of Justice is investigating Johnson & Johnson about whether the company made false claims about its ASR XL hip implants or engaged in questionable marketing of its surgical mesh products. It’s not good news for the global manufacturer that is now defending thousands of lawsuits over both products. The lawsuits allege that the manufacturer failed to warn consumers about known dangers and increased risks of injury. Allegations Of False Claims & Questionable Marketing Practices According to Bloomberg… Read More
The first DePuy hip implant trial is currently underway and is revealing damaging information about the company’s actions concerning the metal-on-metal hip implant system which resulted in the 2010 recall of nearly 100,000 units. Recent testimony showed that DePuy’s president met with a California hip surgeon just months before the recall but never told the hip surgeon about known high failure rates. Failure To Warn Blanketed In Secrecy Secrecy surrounding a lunch meeting between DePuy’s president and high-profile hip implant… Read More
Details in the first DePuy hip replacement lawsuit trial shed more light into why the medical device giant failed to recall its defective ASR hip implants sooner. A recently released deposition of DePuy’s President, Andrew Ekdahl, casts even more doubt on the company’s concerns for safety. Devices Allegedly Not Recalled For Safety Reasons According to a recent Bloomberg article, Ekdahl said that DePuy’s ASR metal-on-metal hip replacement devices were not recalled for safety reasons, but because they, “did not meet… Read More
An expert witness in the first DePuy ASR hip replacement lawsuit to go to trial (In re: Loren Kransky and Sheryl Kransky v. DePuy, Inc., et al., BC456086, Los Angeles Superior Court) recently testified that Johnson & Johnson knew that ASR XL hip replacements had failed internal tests, but kept that information to itself. It’s not a good start for J&J and DePuy as 10,000 more DePuy hip replacement plaintiffs wait in the wings. DePuy Could Have Changed ASR Design,… Read More
